LLNL Nerve Agent Antidote Shows Great Potential

Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02. 

Their work has been showing great promise, and with somw refinement of the LLNL-02 antidote and identifying a second potential candidate molecule, they are working towards approval of LLNL-02 by the FDA. 

You can read all about the work thay have beem doing, and how in this research highlight article from LLNL.